Drug
Epoetin Hospira
Epoetin Hospira: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Epoetin Hospira NCT01628120 | Phase 3 | Chronic Renal Failure Requiring Hemodialysis |
Latest
No recent events.
Follow Epoetin Hospira on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.